Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products worldwide. It is set to report ...
Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...
Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...
His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...
Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on January 31st, the Senator disclosed that they had sold between $1,001 and $15,000 ...
A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...
Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...
Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results